<strong>Central</strong> <strong>nervous</strong> <strong>system</strong> <strong>vasculitis</strong> Hajj-Ali and Calabrese 178 Duna GF, George T, Rybicki L, Calabrese LH. Primary angiitis of the central<strong>nervous</strong> <strong>system</strong>: an analysis of unusual presentations [abstract]. Arthritisrheum 1995; 38 (Suppl 9):S340.9 Calabrese LH, Gragg LA, Furlan AJ. Benign angiopathy: a distinct subset ofangiographically defined primary angiitis of the central <strong>nervous</strong> <strong>system</strong>.J Rheumatol 1993; 20:2046–2050.10 Hajj-Ali RA, Furlan A, Abou-Chebel A, Calabrese LH. Benign angiopathy of thecentral <strong>nervous</strong> <strong>system</strong>: cohort of 16 patients with clinical course and longtermfollow-up. Arthritis Rheum 2002; 47:662–669.11Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review:reversible cerebral vasoconstriction syndromes. Ann Inter Med 2007;146:34–44.This is a very comprehensive review of reversible cerebral vasoconstrictionsyndrome. It is highly recommended for the reading physicians. This review tacklesthe diagnosis, differential diagnosis, and treatment of RCVS.12Ducros A, Boukobza M, Porcher R, et al. The clinical and radiologicalspectrum of reversible cerebral vasoconstriction syndrome: a prospectiveseries of 67 patients. Brain 2007; 130 (Pt 12):3091–3101.This is a large prospective series of RCVS patients. This study describes in detailthe clinical and radiologic findings of RCVS as well and treatment and outcomes.The advantage of this study is its prospective design.13 Hajj-Ali RA, Singhal AB, Calabrese LH. Reversible cerebral vasoconstrictive syndrome [abstract]. Arthritis Rheum 2008; 58(Suppl 9):S906.This is the largest series of RCVS reported to date. This study describes clinicalphenotype, radiologic findings, cerebrospinal fluid findings, pathologic findings,treatment, and outcomes of 120 patients with RCVS.14 Singhal AB, Caviness VS, Begleiter AF, et al. Cerebral vasoconstriction andstroke after use of serotonergic drugs. Neurology 2002; 58:130–133.15 Henry PY, Larre P, Aupy M, et al. Reversible cerebral arteriopathy associatedwith the administration of ergot derivatives. Cephalalgia 1984; 4:171–178.16 Le Coz P, Woimant F, Rougemont D, et al. Benign cerebral angiopathies andphenylpropanolamine. Revue Neurol 1988; 144:295–300.17 Raroque HG Jr, Tesfa G, Purdy P. Postpartum cerebral angiopathy: is there arole for sympathomimetic drugs? Stroke 1993; 24:2108–2110.18 Noskin O, Jafarimojarrad E, Libman RB, Nelson JL. Diffuse cerebral vasoconstriction(Call–Fleming syndrome) and stroke associated with antidepressants.Neurology 2006; 67:159–160.19 Nighoghossian N, Trouillas P, Loire R, et al. Catecholamine syndrome,carcinoid lung tumor and stroke. Eur Neurol 1994; 34:288–289.20 Razavi M, Bendixen B, Maley JE, et al. CNS pseudo<strong>vasculitis</strong> in a patient withpheochromocytoma. Neurology 1999; 52:1088–1090.21 Singhal AB. Cerebral vasoconstriction syndromes. Topics Stroke Rehab 2004;11:1–6.22 Wilkins RH, Odom GL. Intracranial arterial spasm associated with craniocerebraltrauma. J Neurosurg 1970; 32:626–633.23 Lopez-Valdes E, Chang HM, Pessin MS, Caplan LR. Cerebral vasoconstrictionafter carotid surgery. Neurology 1997; 49:303–304.24 Kontos HA, Wei EP, Navari RM, et al. Responses of cerebral arteries andarterioles to acute hypotension and hypertension. Am J Physiol 1978; 234:H371–H383.25 Sigal LH. The neurologic presentation of vasculitic and rheumatologic syndromes:a review. Medicine 1987; 66:157–180.26 Kleinschmidt-DeMasters BK, Gilden DH. Varicella-Zoster virus infections ofthe <strong>nervous</strong> <strong>system</strong>: clinical and pathologic correlates. Arch Pathol Lab Med2001; 125:770–780.27 Mossakowski MJ, Zelman IB. Neuropathological syndromes in the course offull blown acquired immune deficiency syndrome (AIDS) in adults in Poland.Folia Neuropathol 1997; 35:133–143.28 Merritt HH, Adams RD, Solomon HC. Neurosyphilis. New York: OxfordUniversity Press; 1946.29 Kakumani P, Hajj-Ali RA. A forgotten cause of CNS <strong>vasculitis</strong>. J Rheumatol(in press).30 Dawson TM, Starkebaum G. Isolated central <strong>nervous</strong> <strong>system</strong> <strong>vasculitis</strong>associated with hepatitis C infection. J Rheumatol 1999; 26:2273–2276.31 Cacoub P, Sbai A, Hausfater P, et al. <strong>Central</strong> <strong>nervous</strong> <strong>system</strong> involvement inhepatitis C virus infection. Gastroenterol Clin Biol 1998; 22:631–633.32 Oschmann P, Dorndorf W, Hornig C, et al. Stages and syndromes ofneuroborreliosis. J Neurol 1998; 245:262–272.33 Marra CM. Neurologic complications of Bartonella henselae infection. CurrOpin Neurol 1995; 8:164–169.34 Bahemuka M, Murungi JH. Tuberculosis of the <strong>nervous</strong> <strong>system</strong>: a clinical,radiological and pathological study of 39 consecutive cases in Riyadh, SaudiArabia. J Neurol Sci 1989; 90:67–76.35 Barinagarrementeria F, Cantu C. Frequency of cerebral arteritis in subarachnoidcysticercosis: an angiographic study. Stroke 1998; 29:123–125.36 Nishino H, Rubino FA, DeRemee RA, et al. Neurological involvement inWegener’s granulomatosis: an analysis of 324 consecutive patients at theMayo Clinic. Ann Neurol 1993; 33:4–9.37 Moore PM, Calabrese LH. Neurologic manifestations of <strong>system</strong>ic vasculitides.Semin Neurol 1994; 14:300–306.38 Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener’s granulomatosis:prospective clinical and therapeutic experience with 85 patients for 21 years.Ann Inter Med 1983; 98:76–85.39 Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurologicalinvolvement in Behcet’s disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 1999; 122 (Pt 11):2171–2182.40 Al-Araji A, Sharquie K, Al-Rawi Z. Prevalence and patterns of neurologicalinvolvement in Behcet’s disease: a prospective study from Iraq. J NeurolNeurosurg Psychiatry 2003; 74:608–613.41 Brey RL. Neuropsychiatric lupus: clinical and imaging aspects. Bull NYU Hosp Joint Dis 2007; 65:194–199.This article reviews the current literature on clinical and imaging aspects ofneuropsychiatric lupus.42 Ellis SG, Verity MA. <strong>Central</strong> <strong>nervous</strong> <strong>system</strong> involvement in <strong>system</strong>ic lupuserythematosus: a review of neuropathologic findings in 57 cases, 1955–1977. Semin Arthritis Rheum 1979; 8:212–221.43 Hanly JG, Walsh NM, Sangalang V. Brain pathology in <strong>system</strong>ic lupuserythematosus. J Rheumatol 1992; 19:732–741.44 Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primarySjogren syndrome: a study of 82 patients. Medicine 2004; 83:280–291.45 Ando Y, Kai S, Uyama E, et al. Involvement of the central <strong>nervous</strong> <strong>system</strong> inrheumatoid arthritis: its clinical manifestations and analysis by magneticresonance imaging. Inter Med 1995; 34:188–191.46 Vollertsen RS, Conn DL. Vasculitis associated with rheumatoid arthritis.Rheum Dis Clin North Am 1990; 16:445–461.47 Brey RL, Gharavi AE, Lockshin MD. Neurologic complications of antiphospholipidantibodies. Rheum Dis Clin North Am 1993; 19:833–850.48Muscal E, Brey RL. Neurologic manifestations of the antiphospholipid syndrome:integrating molecular and clinical lessons. Curr Rheumatol Rep 2008;10:67–73.An up-to-date review of neurologic manifestations of the APS and discussion of thetherapeutic modalities.49 Meroni PL, Tincani A, Sepp N, et al. Endothelium and the brain in CNS lupus.Lupus 2003; 12:919–928.50 Calabrese LH, Duna GF, Lie JT. Vasculitis in the central <strong>nervous</strong> <strong>system</strong>.Arthritis rheum 1997; 40:1189–1201.51 Dimauro S, Hirano M. Pedaling from genotype to phenotype. Arch Neurol2006; 63:1679–1680.52 Richards A, van den Maagdenberg AM, Jen JC, et al. C-terminal truncations in human 3 0 –5 0 DNA exonuclease TREX1 cause autosomal dominant retinalvasculopathy with cerebral leukodystrophy. Nat Genet 2007; 39:1068–1070.Original mutation description of retinal vasculopathy with cerebral leukodystrophysyndrome.53 Stone JH, Pomper MG, Roubenoff R, et al. Sensitivities of noninvasive testsfor central <strong>nervous</strong> <strong>system</strong> <strong>vasculitis</strong>: a comparison of lumbar puncture,computed tomography, and magnetic resonance imaging. J Rheumatol1994; 21:1277–1282.54 Pierot L, Chiras J, Debussche-Depriester C, et al. Intracerebral stenosingarteriopathies: contribution of three radiological techniques to the diagnosis.J Neuroradiol 1991; 18:32–48.55 Hurst RW, Grossman RI. Neuroradiology of central <strong>nervous</strong> <strong>system</strong> <strong>vasculitis</strong>.Semin Neurol 1994; 14:320–340.56 Greenan TJ, Grossman RI, Goldberg HI. Cerebral <strong>vasculitis</strong>: MR imaging andangiographic correlation. Radiology 1992; 182:65–72.57 Doss-Esper CE, Singhal AB, Smith MS, Henderson GV. Reversible posteriorleukoencephalopathy, cerebral vasoconstriction, and strokes after intravenousimmune globulin therapy in guillain-barre syndrome. J Neuroimag 2005;15:188–192.58 Kadkhodayan Y, Alreshaid A, Moran CJ, et al. Primary angiitis of the central<strong>nervous</strong> <strong>system</strong> at conventional angiography. Radiology 2004; 233:878–882.59 Duna GF, Calabrese LH. Limitations of invasive modalities in the diagnosis ofprimary angiitis of the central <strong>nervous</strong> <strong>system</strong>. J Rheumatol 1995; 22:662–667.60 Calabrese LH. Clinical management issues in <strong>vasculitis</strong>. Angiographicallydefined angiitis of the central <strong>nervous</strong> <strong>system</strong>: diagnostic and therapeuticdilemmas. Clin Exp Rheumatol 2003; 21 (6 Suppl 32):S127–S130.Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
18 Vasculitis syndromes61 Parisi JE, Moore PM. The role of biopsy in <strong>vasculitis</strong> of the central <strong>nervous</strong><strong>system</strong>. Semin Neurol 1994; 14:341–348.62 Cupps TR, Moore PM, Fauci AS. Isolated angiitis of the central <strong>nervous</strong><strong>system</strong>: prospective diagnostic and therapeutic experience. Am J Med 1983;74:97–105.63 Molloy ES, Langford CA. Advances in the treatment of small vessel <strong>vasculitis</strong>.Rheum Dis Clin North Am 2006; 32:157–172.64 Chen D, Nishizawa S, Yokota N, et al. High-dose methylprednisolone preventsvasospasm after subarachnoid hemorrhage through inhibition of proteinkinase C activation. Neurol Res 2002; 24:215–222.65 Turesson C, Matteson EL. Management of extra-articular disease manifestationsin rheumatoid arthritis. Curr Opin Rheumatol 2004; 16:206–211.66 Unger L, Kayser M, Nusslein HG. Successful treatment of severe rheumatoid<strong>vasculitis</strong> by infliximab. Ann Rheum Dis 2003; 62:587–588.67Tokunaga M, Saito K, Kawabata D, et al. Efficacy of rituximab (anti-CD20) forrefractory <strong>system</strong>ic lupus erythematosus involving the central <strong>nervous</strong> <strong>system</strong>.Ann Rheum Dis 2007; 66:470–475.This report describes the clinical and laboratory tests of 10 patients with NPSLEbefore and after rituximab treatment.Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Change language